Smith & Nephew (NYSE:SNN) Rating Lowered to “Buy” at StockNews.com

StockNews.com cut shares of Smith & Nephew (NYSE:SNN) from a strong-buy rating to a buy rating in a research report sent to investors on Tuesday.

SNN has been the topic of several other research reports. Berenberg Bank lowered shares of Smith & Nephew from a “buy” rating to a “hold” rating in a report on Wednesday, November 6th. Deutsche Bank Aktiengesellschaft cut Smith & Nephew from a “buy” rating to a “hold” rating in a research note on Friday, November 1st. Three equities research analysts have rated the stock with a hold rating and two have given a buy rating to the stock. According to data from MarketBeat, the stock has an average rating of “Hold”.

Smith & Nephew Stock Up 1.0 %

Shares of NYSE SNN opened at $24.89 on Tuesday. The company has a current ratio of 2.51, a quick ratio of 1.11 and a debt-to-equity ratio of 0.63. The company has a 50-day simple moving average of $28.74 and a 200-day simple moving average of $27.82. Smith & Nephew has a 12 month low of $23.65 and a 12 month high of $31.72.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently made changes to their positions in the company. Argonautica Private Wealth Management Inc. increased its stake in Smith & Nephew by 6.3% during the 2nd quarter. Argonautica Private Wealth Management Inc. now owns 10,244 shares of the medical equipment provider’s stock worth $254,000 after buying an additional 605 shares during the period. First Trust Direct Indexing L.P. increased its position in shares of Smith & Nephew by 6.9% during the third quarter. First Trust Direct Indexing L.P. now owns 9,659 shares of the medical equipment provider’s stock worth $301,000 after acquiring an additional 626 shares during the last quarter. Inspire Advisors LLC lifted its stake in shares of Smith & Nephew by 3.0% in the second quarter. Inspire Advisors LLC now owns 22,286 shares of the medical equipment provider’s stock worth $552,000 after acquiring an additional 639 shares in the last quarter. Townsquare Capital LLC lifted its stake in shares of Smith & Nephew by 5.4% in the third quarter. Townsquare Capital LLC now owns 14,759 shares of the medical equipment provider’s stock worth $460,000 after acquiring an additional 761 shares in the last quarter. Finally, Rhumbline Advisers boosted its holdings in Smith & Nephew by 8.6% in the second quarter. Rhumbline Advisers now owns 10,365 shares of the medical equipment provider’s stock valued at $257,000 after purchasing an additional 819 shares during the last quarter. 25.64% of the stock is currently owned by hedge funds and other institutional investors.

Smith & Nephew Company Profile

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.